Combined replacement of lnc-MEG3 and miR-155 elicit tumor suppression in multiple myeloma
MEG3 and miR-155 are potential tumor suppressors in MM. Simultaneous overexpression of both biomarkers could represent a novel therapeutic strategy, and their levels could serve as diagnostic and prognostic markers.
Authors
- Amal Darwish
- Nashwa Nagy El-Khazragy (ORCID: https://orcid.org/0000-0001-6646-4674)
- Eman H. A. Hemida (ORCID: https://orcid.org/0009-0007-9221-6595)
- Sara Elsayed Abdelrahman
Institutions
- Ain Shams University (EG)
Publication Details
- Journal
- Epigenomics
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1080/17501911.2025.2453413
- Citations
- 2
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54